C12N 2501/135
Platelet-derived growth factor [pdgf]
Official title: Platelet-derived growth factor [PDGF]
C12N2501/135 (Platelet-derived growth factor [pdgf]) appears on 247 US grants and 514 published applications in this corpus.
Search patents in C12N- Granted patents
- 247
- Published applications
- 514
- Assignees
- 303
- Inventors
- 850
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 2 | 0 |
| 2000 | 2 | 0 |
| 2001 | 1 | 2 |
| 2002 | 1 | 10 |
| 2003 | 5 | 15 |
| 2004 | 3 | 18 |
| 2005 | 2 | 15 |
| 2006 | 7 | 18 |
| 2007 | 5 | 11 |
| 2008 | 4 | 20 |
| 2009 | 7 | 21 |
| 2010 | 12 | 24 |
| 2011 | 10 | 21 |
| 2012 | 10 | 25 |
| 2013 | 6 | 24 |
| 2014 | 13 | 16 |
| 2015 | 19 | 22 |
| 2016 | 12 | 25 |
| 2017 | 17 | 22 |
| 2018 | 20 | 23 |
| 2019 | 16 | 19 |
| 2020 | 11 | 17 |
| 2021 | 8 | 28 |
| 2022 | 5 | 26 |
| 2023 | 10 | 27 |
| 2024 | 12 | 29 |
| 2025 | 12 | 18 |
| 2026 | 9 | 18 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Radial glia and astrocyte differentiation from human pluripotent stem cells8 Sep 2026US 12,729,367 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Methods and compositions for generating oligodendrocyte progenitor cells8 Sep 2026US 12,729,368 B2Trailhead Biosystems Inc.
- Biocompatible conditioned cell medium compositions and uses thereof16 Jun 2026US 12,655,384 B2Cellum Biomedical, Inc.
- Lung fibrosis model and methods of using the same28 Apr 2026US 12,613,236 B2Duke University
- Method to generate induced oligodendrocyte-lineage cells and treatment using such cells17 Feb 2026US 12,553,028 B2Academia Sinica
- Methods and compositions related to platelet releasate and platelet-rich fibrin8 Oct 2026US 2026/0306546 A1Biobridge Global
- Radial Glia and Astrocyte Differentiation from Human Pluripotent Stem Cells24 Sep 2026US 2026/0286296 A1The United States of America, as represented by the Secretary, Dept. of Heath and Human Services
- Induction/differentiation medium for producing of mesenchymal stem cells and application thereof3 Sep 2026US 2026/0258367 A1Hunan Meibo Biomedical Co., Ltd
- Process for preparation of human umbilical cord blood plasma and culture media for tissue regeneration27 Aug 2026US 2026/0250637 A1Iceta - Instituto De CiêNcias, Tecnologias E Agroambiente Da Universidade Do Porto
- Species-Specific Tissue Culture Medium for the Propagation of Cells23 Jul 2026US 2026/0209710 A1SymbioCellTech, LLC
Most cited
By later US patents
- Method for culturing Chinese hamster ovary cells186US 5,633,162 AGlaxo Wellcome Inc. · 1997
- Chemically defined medium for human mesenchymal stem cells174US 5,908,782 AOsiris Therapeutics, Inc. · 1999
- Multiponent adult stem cells and methods for isolation161US 7,015,037 B1M.C.L. Co., Ltd. · 2006
- Making neural cells for human therapy or drug screening from human embryonic stem cells128US 6,833,269 B2Geron Corporation · 2004
- Resurfacing cartilage defects with chondrocytes proliferated without differentiation using platelet-derived growth factor108US 6,001,352 AOsteoBiologics, Inc. · 1999